Clinical trial
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Recruiting now · Not applicable · 1 countries · Registry ID NCT06169033
Recruiting nowNot applicableObservational
What this study is about
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age16 Years to 70 Years
SexAll
Healthy volunteersNot listed
ConditionObesity, Type 2 Diabetes Mellitus, Bariatric Surgery
Full registry criteria
Inclusion Criteria: * BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery Exclusion Criteria: * Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Area under curve (AUC) of the weight loss prediction model after 1 year1 year
This metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 1 year.
Area under curve (AUC) of the T2DM remission prediction model after 1 year1 year
This metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 1 year.
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Yuntao Nie🇨🇳 Beijing, China
Yuntao Nie, M.D.Contact
Hua Meng, M.D.Contact
Yuntao Nie, M.D.Principal Investigator